期刊文献+

生物制剂治疗风湿免疫患者的效果及可行性观察

Effects and feasibility analysis of biologics in the treatment of self-immunity rheumatism
原文传递
导出
摘要 目的 观察生物制剂治疗风湿免疫性疾病患者的临床疗效.方法 选取运城市中心医院治疗的风湿免疫病患者70例作为研究对象,采用数字随机法将患者分为两组,对照组行常规治疗,观察组在对照组基础上选取生物制剂治疗,行视觉模拟评分(VAS)和生活质量评分(QOL),观察C-反应蛋白(CRP)、血沉(ESR)变化情况,并评估临床疗效.结果 观察组治疗有效率为91.43%,显著高于对照组的71.43%,差异有统计学意义(P<0.05).观察组治疗后发热、疼痛、肌肉乏力、皮疹等评分分别为(0.95±0.52)、(0.87±0.44)、(1.05±0.26)、(0.93±0.18)分,均显著低于对照组,差异有统计学意义(P<0.05).观察组治疗后CRP水平为(9.46±7.51) mg/L,明显低于对照组,差异有统计学意义(P<0.05).结论 在抗风湿基础上辅以生物制剂治疗风湿免疫病,可降低CRP、ESR水平,提高临床疗效. Objective To observe the clinical effects of biologics on self-immunity rheumatism.Methods Seventy patients with self-immunity rheumatism were randomly divided into the test group and the control group.The control group were given routine therapy and the test group were treated with biologics based on control group.QOL and VAS were graded and the changes of CRP, ESR were observed.Results The response rate of test group (91.43%) were significantly higher than that of control group (71.43%, P 〈0.05).The scores of fever(0.95 ±0.52), pain(0.87 ±0.44), muscle weakness (1.05 ± 0.26)and skin rash(0.93±0.18) were significantly lower than those of control group (P 〈0.05).The CRP level of test group [(9.46 ± 7.51) mg/L] was significantly lower than that of control group (P 〈 0.05).Conclusions Biologics combined with general anti-rheumatism therapy can decrease CPR level and improve the clinical effects on self-immunity rheumatism.
出处 《中国实用医刊》 2015年第24期48-49,共2页 Chinese Journal of Practical Medicine
关键词 风湿免疫病 生物制剂 视觉模拟评分 临床疗效 Self-immunity rheumatism Biologics VAS scores Clinical effects
  • 相关文献

参考文献6

二级参考文献77

  • 1Genovese MC,Becker JC,Schiff M,et al.Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.N Engl J Med,2005,353:1114.
  • 2Breedveld FC,Weisman MH,Kavanaugh AF,et al.The PREMIER study:A multicenter,randomized,double-blind clinical trial of combination therapy with adalimurnab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early,aggressive rheumatoid arthritis who had not had previous methotrexatc treatment.Arthritis Rheum,2006,54:26.
  • 3Van der Kooij SM,le Cessie S,Goekoop-Ruiterman YP,et al.Clinical and radiological efficacy of initial versus delayed treatment with infliximab plus methotrexate in patients with early rhcumatoid arthritis.Ann Rheum Dis,2009,68:1153.
  • 4Smolen JS,Kay J,Doyle MK,et al.Golimumab in patients with active rheumatoid arthritis after treatment with turnout necrosis factor alpha inhibitors (CO-AFTER study):a multicentre,randomised,double-blind,placebo-controlled,phase Ⅲ trial.Lancet,2009,374:210.
  • 5Kay J,Matteson EL,Dasgupta B,et al.Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate:a randomized,doubleblind,placebo-controlled,doseranging study.Arthritis Rheum,2008,58:964.
  • 6Keystone E,Heijde D,Mason D Jr,et al.Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis:findings of afifty-two-week,phase Ⅲ,multicenter,randomized,doubleblind,placebo-controlled,parallel-group study.Arthritis Rheum,2008,58:3319.
  • 7Fleischmann R,Vencovsky J,van Vollenhoven RF,et al.Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy:the FAST4WARD study.Ann Rheum Dis,2009,68:805.
  • 8Combe B,Codreanu C,Fiocco U,et al.Efficacy,safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanereept alone in patients with rheumatoid arthritis:a double-blind randomised 2-year study.Ann Rheum Dis,2009,68:1146.
  • 9Mertens M,Singh JA.Anakinra for rheumatoid arthritis:a systematic review.J Rheumatol,2009,36:1118.
  • 10Emery P,Keystone E,Tony HP,et al.IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumout necrosis factor biologicals:results from a 24-week multicentre randomised placebo controlled trial.Ann Rheum Dis,2008,67:1516.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部